APA (7th ed.) Citation

CJ, N., KK, S., HR, B., C, D., CJ, D., DJ, H., . . . WM, W. (2026). WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins. Cancer immunology research, 14(3), 434. https://doi.org/10.1158/2326-6066.CIR-25-0558

Chicago Style (17th ed.) Citation

CJ, Nirschl, et al. "WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins." Cancer Immunology Research 14, no. 3 (2026): 434. https://doi.org/10.1158/2326-6066.CIR-25-0558.

MLA (9th ed.) Citation

CJ, Nirschl, et al. "WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins." Cancer Immunology Research, vol. 14, no. 3, 2026, p. 434, https://doi.org/10.1158/2326-6066.CIR-25-0558.